Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2026-01-03 @ 5:12 PM
Study NCT ID:
NCT04190056
Status:
TERMINATED
Last Update Posted:
2023-08-31
First Post:
2019-12-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer
Sponsor:
University of California, San Francisco
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
197520
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |